Gregory CONN

City:

Madrid

Country:

Spain

Published Applications:

Last publication date:

2025-01-16

Top Assignees for applications by Gregory CONN

The entities that hold a legal rights for patent applications filed by inventor CONN Gregory:

PDS BIOTECHNOLOGY CORPORATION 1 Cincinnati, OH United States
PDS BIOTECHNOLOGY COPORATION 1 Princeton, NJ United States

Recent patent applications by CONN Gregory

Gregory CONN from Madrid, ES has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-16

US20250018029A1

Human necessities

METHODS TO ALTER THE TUMOR MICROENVIRONMENT FOR EFFECTIVE CANCER IMMUNOTHERAPY

#2 | 2024-09-26

US20240317833A1

Chemistry; metallurgy

NON-HLA RESTRICTED T CELL VACCINE FOR TCR GAMMA ALTERNATE READING FRAME PROTEIN (TARP) PROTEIN EXPRESSING CANCERS

#3 | 2024-09-26

US20240317828A1

Chemistry; metallurgy

T CELL ACTIVATING IMMUNOTHERAPEUTIC FOR TREATMENT OF MUCIN 1 PROTEIN EXPRESSING HUMAN CANCERS

#4 | 2024-09-26

US20240316178A1

Human necessities

RECOMBINANT PROTEIN VACCINES FORMULATED WITH ENANTIO-SPECIFIC CATIONIC LIPID R-DOTAP AND METHODS OF USE THEREOF

#5 | 2022-02-03

US20220031650A1

Human necessities

STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS

#6 | 2021-11-11

US20210346333A1

Human necessities

STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS

#7 | 2019-10-24

US20190321321A1

Human necessities

METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR STIMULATING TYPE 1 INTERFERON GENES

#8 | 2019-09-12

US20190275145A1

Human necessities

PARTICULATE VACCINE FORMULATIONS

#9 | 2015-04-02

US20150093410A1

Human necessities

Stimulation of an immune response by cationic lipids

InventorID:

1117957 ⎘